Home › Cases › Asthma — Safe Discharge Assessment
Asthma
Asthma — Safe Discharge Assessment
6 questions
Question 1 · Severity on arrival
Correct answer: Acute severe — PEFR 33-50%, HR ≥110, needs treatment but not immediately life-threatening
Why
Acute severe: PEFR 33-50%, HR ≥110, RR ≥25, can't complete sentences. Not yet life-threatening (that requires PEFR <33%, SpO2 <92%, or silent chest). Treat appropriately — but she is not yet imminently arresting.
Key point
Acute severe: PEFR 33-50%, HR ≥110. Life-threatening: PEFR <33%, SpO2 <92%, silent chest, confusion.
Question 2 · Treatment response
Correct answer: PEFR >75% best/predicted after initial treatment, clinically recovered, tolerating oral medicines and no other reason for admission
Why
ED discharge may be considered if PEFR >75% best/predicted one hour after initial treatment, with clinical recovery and treatment manageable at home. Admit any life-threatening attack or severe features persisting after treatment. Significant symptoms, previous near-fatal asthma, pregnancy, poor adherence or inadequate home support may still warrant admission despite good PEFR. These are ED criteria; inpatient discharge needs sustained recovery on home treatment.
Key point
PEFR >75% alone is not discharge clearance. Reassess after initial treatment; persistent severe features or other clinical/social concerns favour admission.
Question 3 · Inhaler technique
Correct answer: Inhaler technique must be assessed by nurse or pharmacist before discharge
Why
Up to 90% of patients use inhalers incorrectly. Poor technique = poor drug delivery. Check technique at every asthma review and especially post-exacerbation. Demonstrate correct technique, watch patient do it, correct errors.
Key point
Check inhaler technique at every exacerbation. Up to 90% use inhalers incorrectly. Watch them do it.
Question 4 · Step up
Correct answer: Start low-dose ICS/formoterol MART — regular maintenance plus the same inhaler for relief
Why
After this severe attack, start low-dose ICS/formoterol MART, alongside acute treatment. Example, if technique is suitable: Symbicort Turbohaler 200/6 micrograms, 1 inhalation twice daily plus 1 as needed. Maximum 6 on one occasion; seek medical advice if needing >8 total/day; 12 total/day only for a limited period. These limits include maintenance doses and are product-specific. SABA alone leaves airway inflammation untreated; never give LABA without ICS because of increased asthma-death risk.
Key point
After a severe attack: low-dose ICS/formoterol MART, with a matching action plan. Never SABA alone or LABA without ICS.
Question 5 · Written action plan
Correct answer: Personalised written green/amber/red plan: daily treatment, worsening symptoms or PEFR, reliever doses and when to call 999
Why
PAAP: match it to her MART inhaler. Green: daily maintenance. Amber: extra MART doses within its written limits; seek review for worsening control. Start a prednisolone rescue course only under explicit written instructions on when, dose and duration; arrange prompt review. Red: an attack or PEFR <50% of personal best needs urgent action. Take 1 MART puff every 1–3 minutes, up to 6; call 999 if worsening at any point or not better after 6. If still not improving and no ambulance after 10 minutes, repeat. Act on symptoms even if PEFR is unchanged.
Key point
Give a personalised action plan at discharge, matched to the reliever: daily treatment, rescue doses and emergency actions. These plans reduce attacks and hospital admissions; do not use PEFR alone.
Question 6 · Follow-up
Correct answer: Within 2 working days of discharge — arrange early post-attack review
Why
Arrange GP/asthma nurse review within 2 working days after emergency care. Review triggers, treatment, adherence and inhaler technique. The BTS Asthma 4 bundle recommends a full clinical review by an asthma-trained professional within 4 weeks, sooner if needed; do not defer it to 8 weeks.
Key point
Early GP/asthma nurse review within 2 working days; full post-attack clinical review within 4 weeks, sooner if needed.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.